We just increased our Investment in ALA - Here’s why
      
        
  
  
  
     
      Next Investors
    
  
        
        Feb 02, 2023
      
      A few weeks ago, a child in the UK received a “base edited” cell therapy for leukaemia. The child went into remission (was cured) within four weeks. We also have an investment in the cell therapy space  Arovella Therapeutics (ASX:ALA), that could be cheaper, more readily available, and more effective than existing cell therapy treatments.